Community Pharmacy England News

- 9TH OCTOBER 2024
- 0 COMMENTS
Improved price concession for Metformin 500mg modified-release tablets for September 2024
Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined the September 2024 concessionary price for Metformin 500mg modified-release tablets: Drug Pack size Price concession Metformin 500mg modified-release tablets 56 £3.26 (previously £2.00) The improved price will apply to prescriptions submitted for
Read more
- Community Pharmacy England News
- 9TH OCTOBER 2024
- 0 COMMENTS
Prime Minister speaks positively about Community Pharmacy during PMQs
The Prime Minister was asked at PMQs today what the Government is doing to improve access to General Practice. In his answer, Sir Keir Starmer said: “We are going to expand the role of community pharmacies and accelerate the roll-out of independent prescribing. We need much more care to be delivered in local communities to
Read more
- Community Pharmacy England News
- 9TH OCTOBER 2024
- 0 COMMENTS
Economic analysis: How much does it cost to run a pharmacy?
Community pharmacy owners are invited to share data to inform an important fiscal review of the sector. Frontier Economics and IQVIA have been commissioned to carry out an economic analysis of community pharmacy on behalf of NHS England. This includes understanding the full economic costs of delivering NHS pharmaceutical services and how these costs vary,
Read more
- Community Pharmacy England News
- 7TH OCTOBER 2024
- 0 COMMENTS
Medicine Supply Notification: Trandate® (labetalol) 50mg tablets
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Trandate® (labetalol) 50mg tablets MSN/2024/101 Tier 2 medium impact Date of issue: 7th October 2024 Trandate® (labetalol) 50mg tablets will be discontinued from July 2025. Alternative low dose beta-blockers remain available. Where these are not suitable, UK manufactured Specials of labetalol
Read more
- Community Pharmacy England News
- 7TH OCTOBER 2024
- 0 COMMENTS
MHRA Class 3 Medicines Recall: Trandolapril 2mg and 4mg capsules (Viatris UK Healthcare Ltd)
MHRA Class 3 Medicines Recall: Trandolapril 2mg and 4mg capsules (Viatris UK Healthcare Ltd) Drug alert number: EL(24)A/47 Date issued: 07 October 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a Class 3 medicines defect information notice for: Trandolapril 2mg and 4mg capsules (Viatris UK Healthcare Ltd) Company name: Viatris UK Healthcare
Read more
- Community Pharmacy England News
- 4TH OCTOBER 2024
- 0 COMMENTS
LPC Chairs Forum convened to advise Community Pharmacy England
A Forum of LPC Chairs, created to provide more local input into the representation of pharmacy owners at a national level, met for the first time last week. The new Forum aims to bring a stronger local voice to national work, steer Community Pharmacy England on local matters, and foster collaboration on areas of mutual
Read more
- Community Pharmacy England News
- 3RD OCTOBER 2024
- 0 COMMENTS
DHSC Hub and Spoke Update
DHSC has informed us that, following the General Election where the progress of these amendments was paused, they are briefing new ministers across all policy areas, including hub and spoke dispensing between different pharmacy owners. As this will take time, they are now not in a position to implement these proposals from 1 January 2025,
Read more
- Community Pharmacy England News
- 3RD OCTOBER 2024
- 0 COMMENTS
Looking to the future: Pharmacy events programme
By Chief Executive Janet Morrison Almost twenty years ago, PSNC (as it was then) set off around the country to talk to pharmacy owners what the new Community Pharmacy Contractual Framework meant for them. The sector was looking forward to a future in which they would be able to offer more clinical services to help
Read more
- Community Pharmacy England News
- 3RD OCTOBER 2024
- 0 COMMENTS
MHRA Class 3 Medicines Recall: Cyanocobalamin 50 mcg Tablets (Glenmark Pharmaceuticals Europe Ltd)
MHRA Class 3 Medicines Recall: Cyanocobalamin 50 mcg Tablets (Glenmark Pharmaceuticals Europe Ltd) Drug alert number: EL(24)A/46 Date issued: 03 October 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a Class 3 medicines defect information notice for: Cyanocobalamin 50 mcg Tablets (Glenmark Pharmaceuticals Europe Ltd) Company name: Glenmark Pharmaceuticals Europe Ltd Product
Read more
- Community Pharmacy England News
- 2ND OCTOBER 2024
- 0 COMMENTS
MHRA Class 4 Medicines Defect Information: Rosuvastatin 20mg, 40mg tablets (Sandoz Ltd)
MHRA Class 4 Medicines Defect Information: Rosuvastatin 20mg, 40mg tablets (Sandoz Ltd) Drug alert number: EL (24)A/45 Date issued: 01 October 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Rosuvastatin 20mg, 40mg tablets (Sandoz Ltd) Company name: Sandoz Ltd Product name: Rosuvastatin 20mg tablets, PL
Read more
- Community Pharmacy England News

Improved price concession for Metformin 500mg modified-release tablets for September 2024

Prime Minister speaks positively about Community Pharmacy during PMQs

Economic analysis: How much does it cost to run a pharmacy?

Medicine Supply Notification: Trandate® (labetalol) 50mg tablets

MHRA Class 3 Medicines Recall: Trandolapril 2mg and 4mg capsules (Viatris UK Healthcare Ltd)

LPC Chairs Forum convened to advise Community Pharmacy England

DHSC Hub and Spoke Update

Looking to the future: Pharmacy events programme

MHRA Class 3 Medicines Recall: Cyanocobalamin 50 mcg Tablets (Glenmark Pharmaceuticals Europe Ltd)

MHRA Class 4 Medicines Defect Information: Rosuvastatin 20mg, 40mg tablets (Sandoz Ltd)

Get in Touch

Working together with key healthcare stakeholders, local councils and other healthcare organisations as necessary to ensure that the provision of pharmaceutical services continues to be an integral part of Health and Social Care